Johnson & Johnson (JNJ) Q2 earnings report 2023


J&J CFO Joseph Wolk on Q2 earnings beat: We're in a very strong position for second half of 2023

Johnson & Johnson on Thursday reported second-quarter revenue and adjusted earnings that topped Wall Street’s expectations, and lifted its full-year guidance as sales from the company’s medtech business jumped.

The medtech division provides devices for surgeries, orthopedics and vision. The company is benefitting from a rebound in demand for non-urgent surgeries among older adults, who deferred those procedures during the pandemic.

That increased demand has been observed by health insurers like UnitedHealth Group and Elevance Health.

Here’s how J&J results compared with Wall Street expectations, based on a survey of analysts by Refinitiv:

  • Earnings per share: $2.80 adjusted, vs. $2.62…

Source cnbc.com

0 0 votes
Article Rating

June home sales drop to the slowest pace in 14 years

Previous article

Kenvue (KVUE) Q2 earnings report 2023

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Earnings